Christopher Sarchi
Corporate Officer/Principal presso REPLIMUNE GROUP, INC.
Patrimonio netto: 830 268 $ in data 30/06/2024
Provenienza dei contatti di primo grado di Christopher Sarchi
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.
70
| Subsidiary | Biotechnology | 70 |
| Public Company | Biotechnology | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Christopher Sarchi tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Stanford University | College/University | Corporate Officer/Principal Masters Business Admin Corporate Officer/Principal Graduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Biotechnology | Founder Chief Executive Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Pharmaceuticals: Major | Founder Chief Executive Officer Corporate Officer/Principal Director/Board Member Director/Board Member | |
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer Corporate Officer/Principal President | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Public Communications Contact Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CARGO THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chairman Director/Board Member | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| KARYOPHARM THERAPEUTICS INC. | Pharmaceuticals: Major | General Counsel Director/Board Member Director/Board Member | |
| ALECTOR, INC. | Biotechnology | Consultant / Advisor President General Counsel | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer Compliance Officer | |
| University of California, Berkeley | College/University | Graduate Degree Graduate Degree Doctorate Degree | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
| RELYPSA INC | Pharmaceuticals: Major | President Chief Executive Officer Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of California, Irvine | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
Replimune Ltd.
 Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Replimune Group, Inc., Replimune Ltd. is a British company that researches and develops cancer therapeutics. The company is based in Abingdon, UK and was founded in 2015. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Public Communications Contact Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Johns Hopkins University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of California, Davis | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree | |
| SANGAMO THERAPEUTICS, INC. | Biotechnology | Director/Board Member Compliance Officer Chief Tech/Sci/R&D Officer | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Public Communications Contact | |
| The Royal Society | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| Oxyrane, Ltd. | Chairman Director/Board Member | ||
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| UNIQURE N.V. | Biotechnology | Chairman Director/Board Member | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Founder | |
| SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Imperial College London | College/University | Doctorate Degree Graduate Degree | |
| LAVA THERAPEUTICS N.V. | Biotechnology | Chairman Director/Board Member | |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Mariana Oncology, Inc.
 Mariana Oncology, Inc. BiotechnologyHealth Technology Mariana Oncology, Inc., also known as Curie Therapeutics, is a radiopharmaceuticals company that specializes in developing safe and effective targeted radiopharmaceuticals for cancer treatment. The company is based in Woburn, MA and was founded by Simon Read, who has been the CEO since incorporation. The company's radiopharmaceuticals are designed to deliver alpha and beta-emitting radionuclide payloads to carefully selected biological targets. | Biotechnology | Director/Board Member Founder | |
| INHIBRX, INC. | Biotechnology | President Chief Tech/Sci/R&D Officer | |
| New York University | College/University | Masters Business Admin Graduate Degree | |
| Georgetown University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 41 |
| Regno Unito | 6 |
| Paesi Bassi | 3 |
| Francia | 2 |
| Belgio | 2 |
Settori
| Health Technology | 29 |
| Consumer Services | 14 |
| Commercial Services | 5 |
| Finance | 3 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 273 |
| Corporate Officer/Principal | 265 |
| Independent Dir/Board Member | 112 |
| Chief Tech/Sci/R&D Officer | 98 |
| Undergraduate Degree | 76 |
Contatti più connessi
| Insiders | |
|---|---|
| Kapil Dhingra | 39 |
| Hugo Slootweg | 34 |
| Dieter Weinand | 32 |
| Marc Tessier-Lavigne | 24 |
| Thomas C. Südhof | 24 |
| John Orwin | 21 |
| Troy Cox | 19 |
| Daniel O'Day | 19 |
| Joseph Slattery | 18 |
| Hyam Levitsky | 18 |
| Jean Franchi | 17 |
| Julie Hambleton | 15 |
| Paolo Pucci | 15 |
| June Lee | 14 |
| Jakob Dupont | 14 |
- Borsa valori
- Insiders
- Christopher Sarchi
- Connessioni Società
